Ligand Pharmaceuticals Incorporated Stock Statistic Functions Linear Regression Slope

LGND Stock  USD 121.47  1.08  0.88%   
Ligand Pharmaceuticals statistic functions tool provides the execution environment for running the Linear Regression Slope function and other technical functions against Ligand Pharmaceuticals. Ligand Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of statistic functions indicators. As with most other technical indicators, the Linear Regression Slope function function is designed to identify and follow existing trends. Ligand Pharmaceuticals statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period to run this model.

Execute Function
The output start index for this execution was nine with a total number of output elements of fifty-two. The Linear Regression Slope is the rate of change in Ligand Pharmaceuticals price series over its benchmark or peer price series.

Ligand Pharmaceuticals Technical Analysis Modules

Most technical analysis of Ligand Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Ligand from various momentum indicators to cycle indicators. When you analyze Ligand charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Ligand Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ligand Pharmaceuticals Incorporated. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ligand Pharmaceuticals Incorporated based on widely used predictive technical indicators. In general, we focus on analyzing Ligand Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ligand Pharmaceuticals's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Ligand Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Ligand Pharmaceuticals, we also check how macroeconomic factors affect Ligand Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Dividend Yield0.480.42
Price To Sales Ratio9.419.2
Hype
Prediction
LowEstimatedHigh
119.72122.40125.08
Details
Intrinsic
Valuation
LowRealHigh
108.43111.11133.62
Details
Naive
Forecast
LowNextHigh
122.30124.98127.66
Details
7 Analysts
Consensus
LowTargetHigh
102.53112.67125.06
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
Business Services Idea
Business Services
Invested few shares
Power Assets Idea
Power Assets
Invested over 200 shares
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
When determining whether Ligand Pharmaceuticals is a strong investment it is important to analyze Ligand Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ligand Pharmaceuticals' future performance. For an informed investment choice regarding Ligand Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Ligand Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ligand Pharmaceuticals. If investors know Ligand will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ligand Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.032
Earnings Share
2.49
Revenue Per Share
8.509
Quarterly Revenue Growth
0.576
Return On Assets
0.013
The market value of Ligand Pharmaceuticals is measured differently than its book value, which is the value of Ligand that is recorded on the company's balance sheet. Investors also form their own opinion of Ligand Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ligand Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ligand Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ligand Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ligand Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ligand Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ligand Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.